MaxCyte, Inc.MXCTNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank85
3Y CAGR+5.7%
5Y CAGR+17.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.7%/yr
vs +30.1%/yr prior
5Y CAGR
+17.9%/yr
Recent deceleration
Acceleration
-24.3pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $78.60M | -5.0% |
| 2024 | $82.72M | -2.5% |
| 2023 | $84.84M | +27.5% |
| 2022 | $66.52M | +37.3% |
| 2021 | $48.44M | +40.6% |
| 2020 | $34.46M | +9.2% |
| 2019 | $31.54M | +35.7% |
| 2018 | $23.25M | +6.5% |
| 2017 | $21.82M | +59.5% |
| 2016 | $13.69M | - |